ArticleRadiology case reports2026
Shrinking hemangiomas amid advancing cirrhosis: A report of 2 cases.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic hemangiomas are the most common benign tumors of the liver. They typically display stable imaging features in non-cirrhotic livers. However, in the setting of cirrhosis, their imaging appearance may change dramatically, posing notable diagnostic challenges during hepatocellular carcinoma (HCC) surveillance. The shrinkage and altered imaging characteristics of hemangiomas in cirrhotic livers likely reflect fibrotic remodeling and changes in hepatic perfusion rather than true lesion involution. We highlight how fibrotic compression, vascular redistribution, and capsular retraction may cause hemangiomas to appear smaller or display atypical features on imaging, posing a diagnostic challenge. These changes can even mimic malignancy transformation, reducing clinical confidence and leading to potential misdiagnosis. Clinicians must remain aware of these potential pitfalls to avoid unnecessary intervention, maintain appropriate management, and approximate the true progression of hemangiomas in the setting of cirrhosis. Here, we report 2 cases of hepatic hemangiomas in patients with cirrhosis that demonstrated apparent regression on serial MRI. In both cases, hemangioma size decreased over time in conjunction with advancing parenchymal fibrosis, increased nodularity, and signs of portal hypertension. Despite the reduction in size, neither patient showed imaging features concerning for malignancy, and both remained stable with respect to liver function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.